Finance

Lists
Why is TTRX down ५.८७%?
Dive Deeper
TTRX:NASDAQ
Turn Therapeutics Inc
US$ ११.३९
-५.८७%
(-०.७१) 1D
अक्टोबर ८, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TTRX...
Open
US$ ११.९४
High
US$ १२.००
Low
US$ ११.२४
Mkt. cap
३४.७४ करोड
Avg. vol.
१.४९ लाख
Volume
०.००
52-wk high
US$ २६.५०
52-wk low
US$ २.५७
EPS
-US$ ०.२९
Shares outstanding
२.९८ करोड
No. of employees
२
Open
US$ ११.९४
High
US$ १२.००
Low
US$ ११.२४
Mkt. cap
३४.७४ करोड
Avg. vol.
१.४९ लाख
Volume
०.००
52-wk high
US$ २६.५०
52-wk low
US$ २.५७
EPS
-US$ ०.२९
Shares outstanding
२.९८ करोड
No. of employees
२
News stories
From web sources and news partners
Kalkine Media
Kalkine Media
·
५७ मिनेट पहिले
Why Is Occidental Petroleum (NYSE:OXY) Climbing as Crude Surges?
www.marketscreener.com
www.marketscreener.com
·
४५ मिनेट पहिले
Altra Fastigheter trades today on Nasdaq Stockholm ex-dividend at SEK 0.75 per share
Bloomberg.com
Bloomberg.com
·
६ घण्टा पहिले
Tech Stocks to Fall as OpenAI Sinks US Chipmakers: Markets Wrap
About Turn Therapeutics Inc
CEO-
Employees२
Founded२०१५
HeadquartersWestlake Village, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to TTRX in the past 3 months
Hold
Buy
2
Hold
0
Sell
2
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TTRX in the last 3 months.
Highest
Current US$ ११.३९
US$ २४.०० (+११०.७१%)
Average
US$ १५.०० (+३१.६९%)
Lowest
US$ १०.०० (-१२.२०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dev Prasad
Lucid Capital
Buy
Initiated
US$ २४.००
+११०.७%
09/24/2026
Karen Sterling
Westpark Capital
Sell
Downgraded
US$ १०.००
-१२.२%
09/14/2026
Unknown Analyst
WBB Securities
Sell
Downgraded
US$ १०.००
-१२.२%
09/14/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Maintained
US$ १६.००
+४०.५%
08/13/2026
Jason Kolbert
D. Boral Capital
Buy
Initiated
US$ ८.००
-२९.८%
12/29/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
४.९७ लाख
४.७८ लाख
६.३९ लाख
Cost of revenue
-
४.९७ लाख
४.७८ लाख
६.३९ लाख
Research and development expenses
१.५९ लाख
३४.९३ हजार
१.०९ लाख
४.७५ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१७.५५ लाख
२१.५९ लाख
११.३७ लाख
११.५३ लाख
Operating expense
१९.१४ लाख
२१.९४ लाख
१२.४६ लाख
१६.२८ लाख
Total operating expenses
१९.१४ लाख
२६.९१ लाख
१७.२४ लाख
२२.६७ लाख
Operating income
-१९.१४ लाख
-२६.९१ लाख
-१७.२४ लाख
-२२.६७ लाख
Other non operating income
४.२६ हजार
२९.५५ लाख
७.०३ लाख
-३३.४२ लाख
EBT including unusual items
-१९.०४ लाख
२.७९ लाख
-९.७१ लाख
-५८.५० लाख
EBT excluding unusual items
-१९.०४ लाख
२.७९ लाख
-९.७१ लाख
-५८.५० लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१९.०४ लाख
२.७९ लाख
-९.७१ लाख
-५८.५० लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-०.०४
-
Interest and investment income
५.११ हजार
१४.१८ हजार
४९.६८ हजार
-
Interest expense
-
-
-
-२.४१ लाख
Net interest expenses
५.११ हजार
१४.१८ हजार
४९.६८ हजार
-२.४१ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१९.०० लाख
-२६.७६ लाख
-१७.०९ लाख
-२२.५२ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू